secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cocrystal Pharma, Inc. (COCP)
CIK:        0001412486
Form:       8-K
Filed at:   2025-10-30T23:59:59+00:00
Accession:  0001493152-25-020143
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cocrystal Pharma raises $1.03M in private placement with four insider investors at $1.39/unit
--------------------------------------------------------------------------------

- Sold 739,426 units (1 share + 2 warrants) at $1.39/unit for $1.03M to four accredited insider purchasers.
- Warrants exercisable at $1.24/share for 27 months; potential additional $1.83M if fully exercised.
- Insiders include Directors Phillip Frost, Fred Hassan, Richard Pfenniger, and co-CEO/CFO James Martin.
- Proceeds to support clinical antiviral development programs and general working capital.
- Offering exempt under Section 4(a)(2) and Regulation D; no registration rights granted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1412486/000149315225020143/0001493152-25-020143-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1412486/000149315225020143/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-020143

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer